Viewing StudyNCT00915252



Ignite Creation Date: 2024-05-05 @ 9:35 PM
Last Modification Date: 2024-10-26 @ 10:06 AM
Study NCT ID: NCT00915252
Status: COMPLETED
Last Update Posted: 2012-12-17
First Post: 2009-06-03

Brief Title: Efficacy of 5-azacytidine Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia AML
Sponsor: University Hospital Muenster
Organization: University Hospital Muenster

Organization Data

Organization: University Hospital Muenster
Class: OTHER
Study ID: 101010
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: University Hospital Muenster
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Amgen INDUSTRY
Celgene Corporation INDUSTRY